195 related articles for article (PubMed ID: 33678581)
21. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
[TBL] [Abstract][Full Text] [Related]
22. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
[TBL] [Abstract][Full Text] [Related]
24. CT Radiomics Features in Differentiation of Focal-Type Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma: A Propensity Score Analysis.
Li J; Liu F; Fang X; Cao K; Meng Y; Zhang H; Yu J; Feng X; Li Q; Liu Y; Wang L; Jiang H; Shao C; Lu J; Bian Y
Acad Radiol; 2022 Mar; 29(3):358-366. PubMed ID: 34108115
[TBL] [Abstract][Full Text] [Related]
25. Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study.
Zhao B; Xia C; Xia T; Qiu Y; Zhu L; Cao B; Gao Y; Ge R; Cai W; Ding Z; Yu Q; Lu C; Tang T; Wang Y; Song Y; Long X; Ye J; Lu D; Ju S
Int J Surg; 2024 Feb; 110(2):740-749. PubMed ID: 38085810
[TBL] [Abstract][Full Text] [Related]
26. A radiomics nomogram model for predicting prognosis of pancreatic ductal adenocarcinoma after high-intensity focused ultrasound surgery.
Shao C; Zhang J; Guo J; Zhang L; Zhang Y; Ma L; Gong C; Tian Y; Chen J; Yu N
Int J Hyperthermia; 2023; 40(1):2184397. PubMed ID: 36888994
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Ductal Adenocarcinoma at CT: A Combined Nomogram Model to Preoperatively Predict Cancer Stage and Survival Outcome.
Cen C; Liu L; Li X; Wu A; Liu H; Wang X; Wu H; Wang C; Han P; Wang S
Front Oncol; 2021; 11():594510. PubMed ID: 34109107
[TBL] [Abstract][Full Text] [Related]
28. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
[TBL] [Abstract][Full Text] [Related]
29. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from
Gao J; Bai Y; Miao F; Huang X; Schwaiger M; Rominger A; Li B; Zhu H; Lin X; Shi K
Clin Radiol; 2023 Oct; 78(10):746-754. PubMed ID: 37487840
[TBL] [Abstract][Full Text] [Related]
30. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
[TBL] [Abstract][Full Text] [Related]
31. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
[TBL] [Abstract][Full Text] [Related]
32. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
[TBL] [Abstract][Full Text] [Related]
33. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
34. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma.
Cao B; Mi K; Dai W; Liu T; Xie T; Li Q; Lang J; Han Y; Peng L; Wang Q
Chin J Cancer Res; 2022 Apr; 34(2):71-82. PubMed ID: 35685995
[TBL] [Abstract][Full Text] [Related]
36. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
[TBL] [Abstract][Full Text] [Related]
37. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma.
Sugimoto M; Farnell MB; Nagorney DM; Kendrick ML; Truty MJ; Smoot RL; Chari ST; Moynagh MR; Petersen GM; Carter RE; Takahashi N
J Gastrointest Surg; 2018 May; 22(5):831-839. PubMed ID: 29392613
[TBL] [Abstract][Full Text] [Related]
38. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.
Salinas-Miranda E; Healy GM; Grünwald B; Jain R; Deniffel D; O'Kane GM; Grant R; Wilson J; Knox J; Gallinger S; Fischer S; Khokha R; Haider MA
Eur Radiol; 2022 Oct; 32(10):6712-6722. PubMed ID: 36006427
[TBL] [Abstract][Full Text] [Related]
39. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
40. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
